There were higher percentages of patients with ischemic stroke of large vessel atherosclerosis (51%) and cardioembolic (4%) origin in Ang II increasers group in comparison to Ang II suppressors group (43% for large vessel atherosclerosis and 3% for cardioembolic, respectively). This evidence concerns the gene AGT and ischemic stroke.